Bailard »

Genes shares owned by Bailard

Quarter-by-quarter ownership of Genes (GCO) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Genes

Tip: Access up to 7 years of quarterly data

All positions including Genes held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genes by Bailard

Quarter filed Position value Share count Share price at filing
2025-09-30 $290k 10k 28.99
2022-03-31 $261k 4.1k 63.66

More positions owned by Bailard

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Eafe Etf (EFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Vanguard World Inf Tech Etf (VGT)
Ishares Tr Calif Mun Bd Etf (CMF)
Gilead Sciences (GILD)
Ishares Tr Ibonds 26 Trm Ts (IBTG)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)

View all positions for Bailard

Top funds holding Genes

Pzena Investment Management
Fund 1 Investments
BlackRock
Vanguard Group
Dimensional Fund Advisors
Acadian Asset Management
Morgan Stanley
Nomura Holdings
D. E. Shaw & Co
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
State Street Corporation
Geode Capital Management
ING Groep
Healthcare Of Ontario Pension Plan Trust Fund

View all funds holding Genes